[135] For instance, liraglutide has shown promise in enhancing nonalcoholic steatohepatitis histology and decelerating fibrosis progression in the Liraglutide Efficacy and Action in Diabetes (LEAD) study, while semaglutide has also exhibited potential in NAFLD treatment
Suzuki M, Betsuyaku T, Ito Y, et al
(28) The crude incidence rates of amputation were 6.1 per 10,000 person-years for GLP-1s, 1.5 for SGLT-2 inhibitors, 4.6 for DPP4-Is, and 1.9 for other agents
A brain-based pain facilitation mechanism contributes to painful diabetic polyneuropathy
The pattern we see most consistently: patients who qualify for Ambetter coverage but have high-deductible Bronze or Silver plans end up paying full brand-name cost for 4 to 6 months before the deductible is satisfied